BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29500907)

  • 1. Alterations in gut microbial function following liver transplant.
    Bajaj JS; Kakiyama G; Cox IJ; Nittono H; Takei H; White M; Fagan A; Gavis EA; Heuman DM; Gilles HC; Hylemon P; Taylor-Robinson SD; Legido-Quigley C; Kim M; Xu J; Williams R; Sikaroodi M; Pandak WM; Gillevet PM
    Liver Transpl; 2018 Jun; 24(6):752-761. PubMed ID: 29500907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.
    Bajaj JS; Fagan A; Sikaroodi M; White MB; Sterling RK; Gilles H; Heuman D; Stravitz RT; Matherly SC; Siddiqui MS; Puri P; Sanyal AJ; Luketic V; John B; Fuchs M; Ahluwalia V; Gillevet PM
    Liver Transpl; 2017 Jul; 23(7):907-914. PubMed ID: 28240840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of intestinal dysbiosis in liver transplant candidates.
    Grąt M; Hołówko W; Wronka KM; Grąt K; Lewandowski Z; Kosińska I; Krasnodębski M; Wasilewicz M; Gałęcka M; Szachta P; Zborowska H; Patkowski W; Krawczyk M
    Transpl Infect Dis; 2015 Apr; 17(2):174-84. PubMed ID: 25728703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.
    Bajaj JS; Salzman N; Acharya C; Takei H; Kakiyama G; Fagan A; White MB; Gavis EA; Holtz ML; Hayward M; Nittono H; Hylemon PB; Cox IJ; Williams R; Taylor-Robinson SD; Sterling RK; Matherly SC; Fuchs M; Lee H; Puri P; Stravitz RT; Sanyal AJ; Ajayi L; Le Guennec A; Atkinson RA; Siddiqui MS; Luketic V; Pandak WM; Sikaroodi M; Gillevet PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut-Liver Axis.
    Bajaj JS; Kakiyama G; Zhao D; Takei H; Fagan A; Hylemon P; Zhou H; Pandak WM; Nittono H; Fiehn O; Salzman N; Holtz M; Simpson P; Gavis EA; Heuman DM; Liu R; Kang DJ; Sikaroodi M; Gillevet PM
    Alcohol Clin Exp Res; 2017 Nov; 41(11):1857-1865. PubMed ID: 28925102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.
    Sydor S; Best J; Messerschmidt I; Manka P; Vilchez-Vargas R; Brodesser S; Lucas C; Wegehaupt A; Wenning C; Aßmuth S; Hohenester S; Link A; Faber KN; Moshage H; Cubero FJ; Friedman SL; Gerken G; Trauner M; Canbay A; Bechmann LP
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00131. PubMed ID: 32352707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis.
    Acharya C; Betrapally NS; Gillevet PM; Sterling RK; Akbarali H; White MB; Ganapathy D; Fagan A; Sikaroodi M; Bajaj JS
    Aliment Pharmacol Ther; 2017 Jan; 45(2):319-331. PubMed ID: 27868217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
    MahmoudianDehkordi S; Arnold M; Nho K; Ahmad S; Jia W; Xie G; Louie G; Kueider-Paisley A; Moseley MA; Thompson JW; St John Williams L; Tenenbaum JD; Blach C; Baillie R; Han X; Bhattacharyya S; Toledo JB; Schafferer S; Klein S; Koal T; Risacher SL; Kling MA; Motsinger-Reif A; Rotroff DM; Jack J; Hankemeier T; Bennett DA; De Jager PL; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn CM; Saykin AJ; Kastenmüller G; Kaddurah-Daouk R;
    Alzheimers Dement; 2019 Jan; 15(1):76-92. PubMed ID: 30337151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
    Kaji K; Takaya H; Saikawa S; Furukawa M; Sato S; Kawaratani H; Kitade M; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Dec; 23(47):8355-8366. PubMed ID: 29307995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.
    Annavajhala MK; Gomez-Simmonds A; Macesic N; Sullivan SB; Kress A; Khan SD; Giddins MJ; Stump S; Kim GI; Narain R; Verna EC; Uhlemann AC
    Nat Commun; 2019 Oct; 10(1):4715. PubMed ID: 31624266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of liver transplantation on the interplay between gut microbiome and bile acid homeostasis in children with biliary atresia.
    Waldner B; Aldrian D; Zöggeler T; Oberacher H; Oberhuber R; Schneeberger S; Messner F; Schneider AM; Kohlmaier B; Lanzersdorfer R; Huber WD; Entenmann A; Müller T; Vogel GF
    Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37184522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normoxic Recovery Mimicking Treatment of Sleep Apnea Does Not Reverse Intermittent Hypoxia-Induced Bacterial Dysbiosis and Low-Grade Endotoxemia in Mice.
    Moreno-Indias I; Torres M; Sanchez-Alcoholado L; Cardona F; Almendros I; Gozal D; Montserrat JM; Queipo-Ortuño MI; Farré R
    Sleep; 2016 Oct; 39(10):1891-1897. PubMed ID: 27397563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
    Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
    World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the gut microbiome in graft fibrosis after pediatric liver transplantation.
    Qin T; Fu J; Verkade HJ
    Hum Genet; 2021 May; 140(5):709-724. PubMed ID: 32920649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of bile acid profile by gut microbiota in chronic hepatitis B.
    Wang X; Chen L; Wang H; Cai W; Xie Q
    J Cell Mol Med; 2020 Feb; 24(4):2573-2581. PubMed ID: 31925905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
    Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
    J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.
    Fukui H
    Gut Liver; 2021 Sep; 15(5):666-676. PubMed ID: 33071239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiome and bile acid metabolome in adult short bowel syndrome.
    Boutte HJ; Chen J; Wylie TN; Wylie KM; Xie Y; Geisman M; Prabu A; Gazit V; Tarr PI; Levin MS; Warner BW; Davidson NO; Rubin DC
    Am J Physiol Gastrointest Liver Physiol; 2022 Jan; 322(1):G154-G168. PubMed ID: 34816756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.